QSI250502P1000
- 0.03
- 0.000.00%
Quantum-Si Newsroom
Press Release: Quantum-Si to Report First Quarter 2025 Financial Results on May 15, 2025
Quantum-Si Updates Corporate Strategy in Proteomics
Quantum-Si Begins Shipping Platinum Pro, Advancing Accessibility in Next-Gen Protein Sequencing
Insider Sale: General Counsel & Corp. Secr. of $QSI Sells 4,896 Shares
Quantum-Si to Participate in DNAnexus Webinar on Large Scale Proteomics in Multi-Omics Research
Healthcare Up as Traders Rotate to Less Inflation-Sensitive Sectors -- Health Care Roundup
Why Precision BioSciences Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Trending Stocks Today | NanoVibronix Rises 15.59% Pre-Market
12 Health Care Stocks Moving In Friday's After-Market Session
$QSI Stock Is up 11% Today. Here's What We See in Our Data.
Express News | Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
A. G. P. Maintains Quantum-Si(QSI.US) With Buy Rating, Cuts Target Price to $3.65
Quantum-Si Price Target Lowered to $3.65 From $3.75 at Alliance Global Partners
Quantum-Si Full Year 2024 Earnings: EPS Misses Expectations
Q4 2024 Quantum-Si Inc Earnings Call
Cautious Optimism for Quantum-Si Amid Market Position and Funding Uncertainties
H.C. Wainwright Maintains Quantum-Si(QSI.US) With Buy Rating, Maintains Target Price $5.5
Quantum-Si's Strategic Growth and Financial Strength Drive Buy Rating
Quantum-Si Reports Milestone Revenue and Strategic Growth